Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox as adjunctive therapy for mucormycosis
IRCT20210429051130N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of deferasirox in mucormycosis, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Nov 2021; status: completed.
02
Drugs
deferasirox
03
Conditions
mucormycosis
Beyond the preview
Go deeper on IRCT20210429051130N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210429051130N2.